A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients
Shereck, Evan B., Cooney, Erin, van de Ven, Carmella, Della-Lotta, Phyllis, Cairo, Mitchell S.
Published in Pediatric Blood & Cancer (01.09.2007)
Published in Pediatric Blood & Cancer (01.09.2007)
Get full text
Journal Article